PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed for an initial public offering that could value it at well over $1 billion, sources familiar with the matter have shared privately. The IPO would be […]
0
PharmaCann
1
About Us
The Dank Investor is an industry leading cannabis financial services company providing breaking market news, analysis and leading insights about cannabis stocks for investors to grow their portfolios and minimize risk. Markets include NASDAQ, NYSE, OTC and other markets. Additionally, the company provides business services to companies in the cannabis sector through comprehensive corporate communication and marketing solutions.
The Dank Investment Community encompasses an engaged social media audience of over 50,000 who leverage our content to stay informed as investors.
We seek Safe Harbor.
Recent Posts
- Ascend Wellness Holdings Address CEO Abner Kurtin Battery Arrest
- Green Sentry Holdings Completes Acquisition of MedMen Florida License and Assets
- Curaleaf Launches New Plant Precision Product Line Expanding Portfolio in Health and Wellness Categories
- Heritage Cannabis Announces New Environmental and Social Responsibility Initiative
- Sweet Leaf Madison Capital Provides Funding for Cannabis Company Driven Grow to Accelerate Growth
